Replies to post #4224 on LadRx Corp (LADXD)

[Tekterra]

From the current Tutes holding shares they are recent ones which means Tutes bought in at offering price or at warrant price. They would take a 4$ per share and run with huge profits no doubt about that. That falls in line with the talk that Sk was in bed with Tutes. More dots connected.

Cytrx is not the first ticker that had some misleading trial results released that caused a huge share price drop, only later to get run up in dollars again from 50 cents. There shouldn't be Tutes holding shares if Aldox was worthless like some trying to bash this.

Don't forget we have a product that completed a phase 3 with success. Phase 1 to address safety, phase 2 to show effectiveness, and a phase 3 to compare with existing treatment with positive results as well as a clear FDA approval path.

For once, I am actually hoping SK get that deal through even if it was 4$ lol.

[tsoprano-1]

N3, if you think that is the price, which I would gladly take, look for the buyer to run it up a bit before hand. I believe they can get 10% before having to file, so may as well buy some cheap stock under a dollar. And should it get close to a buck, shorts and profit takers will come in to provide more shares. Won't they be surprised when a filing for Novartis saying they own 10% goes thru. Or some other big pharma.

T